Overall I’m happy with the results. Growth in receivables looks solid, the end looks to be in sight for the exit costs from the products which are winding up which will boost cash NP.
However the main point I’m looking forward to is the dividends being based on the normalised result, which should increase the yield and the SP respectively in my view.
One thing I noticed is the receivables book increased circa $534M, however HUM only funded $418M of this through the warehouse facility, another $50M was funded via the corporate debt loan. Why would they do this?? This baffles me.
- Forums
- ASX - By Stock
- Ann: HUM - financial results briefing for HY ended 31 Dec 2022
Overall I’m happy with the results. Growth in receivables looks...
Featured News
Add HUM (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.0¢ |
Change
0.015(2.04%) |
Mkt cap ! $368.8M |
Open | High | Low | Value | Volume |
73.5¢ | 76.5¢ | 73.0¢ | $183.4K | 244.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 105434 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 2804 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 105434 | 0.750 |
1 | 30000 | 0.740 |
1 | 8163 | 0.735 |
3 | 14432 | 0.730 |
1 | 20000 | 0.720 |
Price($) | Vol. | No. |
---|---|---|
0.765 | 57262 | 1 |
0.780 | 5840 | 2 |
0.785 | 18584 | 2 |
0.800 | 39041 | 5 |
0.820 | 6200 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online